Hmm, it is quite tricky. if they capitalized on the development and still have to account for Patent value, it will be double counting i think.
says the value is USD25 M as per what they deem as value of patent (commercially) then they need to add that into their BS.
Ann: NeuRizer Corporate Update, page-41
Add NRZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.724M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| NRZ (ASX) Chart |
Day chart unavailable